Tricyclic heteroaryl-substituted quinoline and azaquinoline compounds as PAR4 inhibitors
US-12528827-B2 · Jan 20, 2026 · US
This page is not indexed by search engines while we improve data quality.
Priestley Eldon Scott patents
Priestley Eldon Scott is listed as an inventor on 38 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Priestley Eldon Scott |
| Total patents | 38 |
| First publication | Apr 2, 2015 |
| Latest publication | Jan 20, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
US-2025002497-A1 · Jan 2, 2025 · US
Substituted nitrogen containing compounds
US-2024327390-A1 · Oct 3, 2024 · US
Tricyclic heteroaryl-substituted quinoline and azaquinoline compounds as par4 inhibitors
US-2024309019-A1 · Sep 19, 2024 · US
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation
US-12084452-B2 · Sep 10, 2024 · US
Bicyclic heteroaryl substituted compounds
US-12060347-B2 · Aug 13, 2024 · US
Biarylmethyl heterocycles
US-12037324-B2 · Jul 16, 2024 · US
Tricyclic heteroaryl-substituted quinoline and azaquinoline compounds as PAR4 inhibitors
US-11932658-B2 · Mar 19, 2024 · US
Substituted nitrogen containing compounds
US-RE49700-E · Oct 17, 2023 · US
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
US-2023242535-A1 · Aug 3, 2023 · US
Recent patents
Latest publications not already listed above.
Substituted nitrogen containing compounds
US-2023124468-A1 · Apr 20, 2023 · US
Biarylmethyl heterocycles
US-2023045357-A1 · Feb 9, 2023 · US
Biarylmethyl heterocycles
US-11407733-B2 · Aug 9, 2022 · US
Tricyclic heteroaryl-substituted quinoline and azaquinoline compounds as par4 inhibitors
US-2021188877-A1 · Jun 24, 2021 · US
Bicyclic heteroaryl substituted compounds
US-2021163465-A1 · Jun 3, 2021 · US
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation
US-10822343-B2 · Nov 3, 2020 · US
Substituted nitrogen containing compounds
US-2020339550-A1 · Oct 29, 2020 · US
Monocyclic heteroaryl substituted compounds
US-10815224-B2 · Oct 27, 2020 · US
Bicyclic heteroaryl substituted compounds
US-10730868-B2 · Aug 4, 2020 · US
Substituted bicycle heterocyclic derivatives useful as ROMK channel inhibitors
US-10723723-B2 · Jul 28, 2020 · US
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (par4) inhibitors for treating platelet aggregation
US-2020123160-A1 · Apr 23, 2020 · US
Substituted nitrogen containing compounds
US-2020109135-A1 · Apr 9, 2020 · US
Substituted nitrogen containing compounds
US-10501449-B2 · Dec 10, 2019 · US
Tricyclic heteroaryl-substituted quinoline and azaquinoline compounds as par4 inhibitors
US-2019315774-A1 · Oct 17, 2019 · US
Bicyclic heteroaryl substituted compounds
US-2019300520-A1 · Oct 3, 2019 · US
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation
US-10428077-B2 · Oct 1, 2019 · US
Monocyclic heteroaryl substituted compounds
US-2019248771-A1 · Aug 15, 2019 · US
Substituted bicycle heterocyclic derivatives useful as romk channel inhibitors
US-2019248769-A1 · Aug 15, 2019 · US
Biarylmethyl heterocycles
US-2019202808-A1 · Jul 4, 2019 · US
Substituted nitrogen containing compounds
US-2018346453-A1 · Dec 6, 2018 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Bristol Myers Squibb Co | 38 |
| Univ Montreal | 15 |
| Univ Monteal | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P7/02 | 25 |
| A61P9/00 | 25 |
| A61K31/4439 | 25 |
| C07D513/04 | 21 |
| A61K31/497 | 21 |